Press release
Global Hypertensive Emergency Medications Market Scenario Highlighting Major Drivers & Trends, 2018-2028 / Key Players Baxter Laboratories Pty Ltd.; NuCare Pharmaceuticals, Inc.; Pfizer Inc.; Exela Pharma Sciences LLC; Nexus Pharmaceuticals, Inc.; Novarti
The growing prevalence of hypertension is expected to be a major factor driving the Hypertensive Emergency Medications Market over the forecast period. The rise in geriatric population is also boosting the market of hypertensive emergency medications. Unhealthy lifestyle is also contributing to the growing prevalence of various cardiovascular system disorders, which is also boosting the hypertensive emergency medications market.Request a Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1298
Hypertensive emergency is the sudden elevation of blood pressure with signs of damage to the target organs such as the brain, kidneys and cardiovascular system. Hypertensive emergency medications are the immediate treatment required to reduce elevated blood pressure to prevent further damage to the organs. In a hypertensive emergency, acute organ damage has already occurred, and it requires blood reduction within one hour to prevent further damage to organs. Patients need effective medications to lower the elevated blood pressure and to protect target organ function. Neurologic end-organ damage due to hypertensive emergencies includes cerebral infarction, subarachnoid haemorrhage and others. Cardiovascular end-organ damage includes myocardial infarction, ventricular dysfunction, aortic dissection and others. With the advent of hypertensive emergency medications, the incidence of hypertension emergencies has decreased. Patients need rapidly acting medication administered intravenously to lower the elevated blood pressure.
The traditional drug for treating hypertensive emergency is sodium nitroprusside. The amount of dosage and the drug choice varies according to the type of disorder. Patients with acute myocardial infarction need to be treated with intravenous esmolol. There are several drugs to choose from for the management of hypertensive emergencies, which include nitroglycerin, labetalol, fenoldopam, nicardipine and clevidipine, among others. According to NCBI, total hypertensive emergencies have increased by 16.2% per year from 2006 to 2013.
However, various adverse effects associated with the usage of drugs is hampering the growth of the hypertensive emergency medications market. Lack of awareness among individuals is also expected to restrain the growth of the hypertensive emergency medications market during the forecast period.
Request Full Report with TOC: https://www.factmr.com/report/1298/hypertensive-emergency-medications-market
The global market for Hypertensive Emergency Medications is expected to grow at a significant rate over the forecast period. Effective management of hypertensive emergency requires careful considerations of aetiology and the indicated treatment. Nitroprusside has been one of the most commonly used hypertensive emergency medications because of its rapid onset and effectiveness. However, its usage has been decreasing owing to awareness about its level of toxicity. Nowadays, it is used in combination with other drugs to decrease the toxicity level. Several clinical studies have to be performed to improve the treatment and lower the adverse effects of hypertensive emergency medications. The intravenous route of drug administration is the most common form of administration for several drugs because of its rapid effect.
Hypertensive Emergency Medications Market: Regional Outlook
Geographically, the global hypertensive emergency medications market has been segmented into North America, Latin America, Europe, Asia-Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global hypertensive emergency medications market owing to the high prevalence diseases and rise in geriatric population. In addition, a large number of key players offering hypertensive emergency medications are present in this region. Europe is expected to hold the second-largest share in the global hypertensive emergency medications market throughout the forecast period due to the availability of better healthcare facilities. The hypertensive emergency medications market in Asia Pacific is expected to grow at a significant CAGR due to rise in elderly population. However, Middle East and Africa is expected to register slower growth due to lack of awareness among individuals as well as poor healthcare facilities.
Hypertensive Emergency Medications Market: Key Players
The global market for hypertensive emergency medications is highly fragmented. Some of the key players operating in the global hypertensive emergency medications market are Alvogen, Inc.; Baxter Laboratories Pty Ltd.; NuCare Pharmaceuticals, Inc.; Pfizer Inc.; Exela Pharma Sciences LLC; Nexus Pharmaceuticals, Inc.; Novartis International AG and F. Hoffmann-La Roche AG.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Connect To An Expert: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1298
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hypertensive Emergency Medications Market Scenario Highlighting Major Drivers & Trends, 2018-2028 / Key Players Baxter Laboratories Pty Ltd.; NuCare Pharmaceuticals, Inc.; Pfizer Inc.; Exela Pharma Sciences LLC; Nexus Pharmaceuticals, Inc.; Novarti here
News-ID: 1473648 • Views: …
More Releases from Fact.MR

Insulation Blow-in Machine Market is Estimated to be US$ 1,086.9 Million with a …
The global insulation blow-in machine market is projected to increase from USD 552.5 million in 2025 to USD 1,086.9 million by 2035, with a CAGR of 7% during the forecast period. Growth is driven by a rising trend in DIY and home improvement activities, boosting demand for portable insulation blow-in machines. Their effortless operation and convenient handling make them ideal for householders and contractors.
For More Insights into the Market, Request…

Hydrocyclone Market Demand Rising at a Stellar 6.5 % CAGR to Reach USD 1,466.8 M …
The global hydrocyclone market is projected to increase from USD 781.4 million in 2025 to USD 1,466.8 million by 2035, with a CAGR of 6.5% during the forecast period. Growth is driven by rising demand for efficient solid-liquid separation in mining, wastewater treatment, and chemical processing.
Hydrocyclones are ideal for efficient solid-liquid separation due to their compact design, high throughput capacity, energy efficiency, and enhanced durability with advanced ceramic linings.
For More…

Hydraulic Gear Pump Market Set to Surge at 4.4 % CAGR, to Reach US$ 3.4 Billion …
The global hydraulic gear pump market is projected to increase from USD 2.2 billion in 2025 to USD 3.4 billion by 2035, with a CAGR of 4.4% during the forecast period. Growth is driven by increased mechanization in construction and agriculture, integration of energy-efficient systems, and opportunities from industrial automation.
Hydraulic gear pumps are ideal for powering heavy machinery in construction, agricultural equipment, and industrial automation, improving machinery performance and productivity.
For…

Heating Cable Market to Rise at CAGR of 5.4% to Reach US$ 2.9 Billion by 2035: F …
The global heating cable market is projected to grow from USD 1.7 billion in 2025 to USD 2.9 billion by 2035, registering a CAGR of 5.4% during the forecast period. This growth is primarily driven by the rising emphasis on frost protection, pipe freeze prevention, and underfloor heating systems in colder regions.
Rapid urbanization, infrastructure development, and the adoption of smart technologies are further accelerating demand for self-regulating and constant wattage…
More Releases for Hypertensive
Anti-Hypertensive Drugs Market is Dazzling Worldwide and Forecast to 2031
The global anti-hypertension drugs market is estimated to grow at a CAGR of over 4% during the forecast period. Hypertension is a common condition among patients with diabetes. Hence, the adoption of anti-hypertensive is high among the diabetic population for the treatment of hypertension. Hence, the increased diabetic population coupled with the adoption of anti-hypertensive drugs is anticipated to drive the anti-hypertensive drug market industry significantly. Additionally, Angiotensin-converting enzyme (ACE)…
Hypertensive Crisis Agents Market - Empowering Emergency Response: Hypertensive …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hypertensive Crisis Agents Market.
Hypertensive Crisis Agents Market: https://www.growthplusreports.com/report/hypertensive-crisis-agents-market/9142
The Hypertensive Crisis Agents Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Anti-Hypertensive Drugs Market Analysis and Forecast up to 2030
Can Anti-hypertensive Drugs Worsen Condition of COVID-19 Patients?
Anti-hypertensive drugs are under scrutiny for reducing the symptoms of COVID-19 (coronavirus). However, in many research journals, it has been found that these drugs carry the potential risk of increasing the abundance of SARS-CoV-2 receptors, which is the virus that causes coronavirus.
As such, these claims are being argued by Carlos Ferrario, a professor of general surgery at the Wake Forest School of Medicine.…
Global Hypertensive Heart Diseases Market, Size, Share, Analysis Report & Foreca …
The global hypertensive heart diseases market is anticipated to grow at a CAGR of around 3.5% during the forecast period (2021-2027). The prevalence of hypertensive heart disease in North America is the major factor driving the growth of the region. The growing aging population in the US accelerating the demand for hypertensive heart disease treatments and drugs. As per the Urban Institutes, the aging population over 65 in America is…
Anti-Hypertensive Drugs Market Trends 2020 | Segmentation, Outlook, Industry Rep …
The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased…
Anti-Hypertensive Drugs Market Size & Growth Analysis Report, 2020-2026
The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased…